Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine

NCT07683949 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ENROLLING_BY_INVITATION

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Advanced Colorectal Cancer (Part 1)

Interventions

COMBINATION_PRODUCT: Lenvanib (Lenvatinib),Xeloda (capecitabine)

Sponsor

Seoul National University Bundang Hospital

Collaborators

[object Object]